Literature DB >> 29525383

Update on off label use of metformin for obesity.

Amr Ahmed El-Arabey1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29525383     DOI： 10.1016/j.pcd.2018.02.004

Source DB:  PubMed          Journal:  Prim Care Diabetes        ISSN： 1878-0210            Impact factor:   2.459


× No keyword cloud information.
  5 in total

Review 1.  Anticancer activity of metformin: a systematic review of the literature.

Authors:  Mohamad Aljofan; Dieter Riethmacher
Journal:  Future Sci OA       Date:  2019-08-22

2.  Metformin use and long-term risk of benign prostatic hyperplasia: a population-based cohort study.

Authors:  Mette Nørgaard; Bianka Darvalics; Reimar Wernich Thomsen
Journal:  BMJ Open       Date:  2020-12-22       Impact factor: 2.692

3.  Outcome and death risk of diabetes patients with Covid-19 receiving pre-hospital and in-hospital metformin therapies.

Authors:  Rodrigo Esaki Tamura; Said Muhammad Said; Leticia Mussin de Freitas; Ileana Gabriela Sanchez Rubio
Journal:  Diabetol Metab Syndr       Date:  2021-07-13       Impact factor: 3.320

4.  Metformin and COVID-19: A novel deal of an old drug.

Authors:  Amr Ahmed El-Arabey; Mohnad Abdalla
Journal:  J Med Virol       Date:  2020-06-03       Impact factor: 20.693

5.  Repurposing Cardio-Metabolic Drugs to Fight Covid19.

Authors:  Allegra Battistoni; Massimo Volpe
Journal:  High Blood Press Cardiovasc Prev       Date:  2021-09-15
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.